Conference Coverage (AASLD)

Higher Dose HBV Vaccine Needed for OLT Candidates

Published in Blood Weekly, December 15th, 1997

An accelerated schedule of hepatitis B vaccination may be needed in liver transplant candidates with end stage liver disease, but the dosage should be doubled to at least 40 (mu)g HBs Ag per injection, according to a study from Germany's University of Heidelberg.

Researcher B. Kallinowski and colleagues found that only one-third of the orthotopic liver transplant (OLT) candidates given accelerated schedules of hepatitis B vaccine with standard dosages developed protective antibodies.

Kallinowski et al. presented the results of this study at the 48th Annual Meeting of the American Association for the Study of Liver Diseases, held November 7-11, 1997...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1997-12-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry